Expert Interviews

May 24, 2021

Ophthalmologists and industry KOLs share what lingers on their minds at the end of the day.

May 24, 2021

The most common types of artificial tears recommended to help manage dry eye disease and the importance of proper use for full benefit.

May 24, 2021

Eye care professionals discuss their comfort in recommending oral omega-3 fatty acids to help treat dry eye disease.

May 17, 2021

How to select and discuss sequential therapy with patients who have dry eye disease and set expectations for treatment.

May 17, 2021

Resources and strategies that can be used to help educate patients about dry eye disease and optimize adherence to therapy.

May 10, 2021

Criteria that would prompt further evaluation for dry eye disease and the types of tests used to work-up and accurately diagnose the condition.

May 10, 2021

Eye care professionals explain the impact of unstable tear film and untreated dry eye disease on patient quality of life.

May 07, 2021

Michael A. Singer, MD, speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).

May 07, 2021

Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices.

May 06, 2021

Christopher Starr, MD, discusses key points from his virtual ARVO 2021 presentation regarding dry eye disease flares, including a rapid readout assessment of 10 years' worth of world literature to analyze studies in which the inflammatory disease's condition are categorized.